No Detail Found!

Serum lipids in schizophrenic patients on typical anti psychotic medication.

Author(s)
Ahmad Rafiq Department of Pathology, Khyber Medical College, Peshawar, Pakistan
S. M. Sultan Department of Pathology, Khyber Medical College, Peshawar, Pakistan
Zahid Nazar Department of Pathology, Khyber Medical College, Peshawar, Pakistan
Khalid A. Mufti Department of Pathology, Khyber Medical College, Peshawar, Pakistan
Mohammad Tayab Department of Pathology, Khyber Medical College, Peshawar, Pakistan
Abstract
Atypical antipsychotics are replacing typical antipsychotics in psychiatric practice because of their propensity to cause less extrapyramidal side effects. However their adverse effects on lipid profile weight gain and hyperglycemia is the reason to switch back to typical antipsychotics. So we planned a study to see the effect of typical antipsychotic medication on lipid profile. 40 subjects aged 15-45 years, selected randomly were grouped age-wise as I (15-30 years) and II (31-45 years). Subjects were divided into Group-P (20 schizophrenic patients on typical medication) and Group-C (20 age, sex matched normal controls). Serum total cholesterol (TC), serum triglyceride (TG) and serum high density lipoprotein cholesterol (HDL-C) were measured. Serum low density lipoprotein cholesterol (LDL-C was calculated with Friedwald equation, results obtained were analyzed by using student ‘t’ test and level of significance was obtained. Significantly decreased levels of TG, LDL were found in younger age Group-1 (15-30years) and decreased level of HDL C were found in adult Group-II (31-45 years). We conclude that typical antipsychotics have favorable lipid profile and can be reserved for use in diabetic, hypertensive and hyperlipidemic patients suffering from schizophrenia.
Publication Details
Page(s) 134-136
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 12, Issue: 2, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

20

Views